CSF3R and head and neck neoplasm: We identified infiltrating neutrophils in head and neck tumors by selecting the myeloid cells with the highest expression of CSF3R (17% of myeloid cells, 1.15% of CD45+ cells) in silico, similar to what was used to define neutrophils in CD45+ cells in a recent myeloid lung cancer atlas (35).